Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma-Reference-Cited by-同舟云学术

Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma

Published:2012-06 Issue:3 Volume:76 Page:431-438
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Ishikawa Masashi,Miyahara Ryo,Sonobe Makoto,Horiuchi Marika,Mennju Toshi,Nakayama Ei,Kobayashi Masashi,Kikuchi Ryutaro,Kitamura Jiro,Imamura Naoto,Huang Cheng-Long,Date Hiroshi

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference42 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience;Naruke;Ann Thorac Surg,2001

3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995; 311: p. 899–909

4. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data;Arriagada;Lancet,2010

5. Targeted therapy for the treatment of non-small cell lung cancer: focus on inhibition of epidermal growth factor receptor;Harichand-Herdt;Semin Thorac Cardiovasc Surg,2008

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive analysis of EphA2 in pan‐cancer: A prognostic biomarker associated with cancer immunity;Clinical and Experimental Pharmacology and Physiology;2024-06-17

2. Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma;Frontiers in Genetics;2023-06-07

3. May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?;International Journal of Molecular Sciences;2022-12-21

4. Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies;International Journal of Molecular Sciences;2022-09-22

5. EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma;Cancer Cell International;2021-10-13